Abeona Therapeutics (ABEO) Intangibles (2010 - 2022)

Abeona Therapeutics' Intangibles history runs 12 years deep, the most recent figure standing at $2.2 million for Q3 2022.

• On a quarterly basis, Intangibles rose 52.58% year-over-year to $2.2 million in Q3 2022; TTM through Sep 2022 was $2.2 million, a 52.58% increase from a year earlier, with the FY2021 full-year figure at $1.4 million, down 35.81% from the prior year.
• Intangibles steadied at $2.2 million in Q3 2022 per ABEO's latest filing, from $2.2 million in the prior quarter.
• Across five years, Intangibles topped out at $44.9 million in Q4 2018 and bottomed at $1.4 million in Q4 2021.
• The 5-year median for Intangibles is $2.6 million (2020), against an average of $13.0 million.
• Across the five-year window, Intangibles surged 1046.25% in 2019 and sank 94.94% in 2020, its largest moves.
• Year by year, Intangibles stood at $44.9 million in 2018, then dropped by 5.02% to $42.6 million in 2019, then sank by 94.94% to $2.2 million in 2020, then slumped by 35.81% to $1.4 million in 2021, then soared by 55.78% to $2.2 million in 2022.
• Per Business Quant, the three latest ABEO Intangibles figures stand at $2.2 million (Q3 2022), $2.2 million (Q2 2022), and $2.2 million (Q1 2022).